| Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma |
19 |
| High-Risk Human Papillomavirus in Oral Cancer: Clinical Implications |
17 |
| Usefulness of Plasma Exosomal MicroRNA-451a as a Noninvasive Biomarker for Early Prediction of Recurrence and Prognosis of Non-Small Cell Lung Cancer |
15 |
| Prognostic Impact of miR-200 Family Members in Plasma and Exosomes from Tumor-Draining versus Peripheral Veins of Colon Cancer Patients |
14 |
| Correlation between Early Tumor Marker Response and Imaging Response in Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib |
12 |
| A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors |
11 |
| Value of Intraoperative Cytological and Pathological Sentinel Lymph Node Diagnosis in Fertility-Sparing Trachelectomy for Early-Stage Cervical Cancer |
11 |
| Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular Carcinoma |
10 |
| Endoscopic Diagnostic Support System for cT1b Colorectal Cancer Using Deep Learning |
10 |
| A Phase II Study of Irinotecan for Patients with Previously Treated Small-Cell Lung Cancer |
9 |
| Diagnostic Accuracy of F-18 FDG PET/CT for Preoperative Lymph Node Staging in Newly Diagnosed Bladder Cancer Patients: A Systematic Review and Meta-Analysis |
9 |
| Targeting SHP- 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment? |
9 |
| The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma |
9 |
| Chimeric Antigen Receptor T-Cell Therapy: Reach to Solid Tumor Experience |
8 |
| Pretreatment Neutrophil-to-Lymphocyte Ratio Was a Predictor of Lymph Node Metastasis in Endometrial Cancer Patients |
8 |
| Clinical Characteristics and Prognosis of Pregnancy-Associated Breast Cancer: Poor Survival of Luminal B Subtype |
8 |
| A Pan-Cancer Landscape Analysis Reveals a Subset of Endometrial Stromal and Pediatric Tumors Defined by Internal Tandem Duplications of BCOR |
8 |
| Stool-Based miR-92a and miR-144*as Noninvasive Biomarkers for Colorectal Cancer Screening |
8 |
| A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma |
8 |
| Making the Best of Available Options for Optimal Sarcoma Treatment |
7 |
| Molecular Epidemiology of ALK Rearrangements in Advanced Lung Adenocarcinoma in Latin America |
7 |
| Long-Term Survival and Cure in Distant Metastatic Breast Cancer |
7 |
| ZNF750 Expression Is a Potential Prognostic Biomarker in Esophageal Squamous Cell Carcinoma |
7 |
| Bevacizumab in Combination with Platinum-Based Chemotherapy in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with or without Brain Metastases: A French Cohort Study (EOLE) |
6 |
| Prognostic Factors Associated with Postprogression Survival in Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib Not Eligible for Second-Line Regorafenib Treatment |
6 |
| TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma |
6 |
| Impact of Gastric Cancer Surgery in Elderly Patients |
6 |
| Different Toxicity of Cetuximab and Panitumumab in Metastatic Colorectal Cancer Treatment: A Systematic Review and Meta-Analysis |
6 |
| Early PD-1 Therapy Discontinuation in Responding Metastatic Cancer Patients |
6 |
| Expression Levels of microRNAs miR-93 and miR-200a in Pancreatic Adenocarcinoma with Special Reference to Differentiation and Relapse-Free Survival |
6 |
| Dental Cone Beam Computed Tomography in Children: Clinical Effectiveness and Cancer Risk due to Radiation Exposure |
5 |
| Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study |
5 |
| Brain Metastases from Biliary Tract Cancer: A Monocentric Retrospective Analysis of 450 Patients |
5 |
| Prognostic Impact of Microsatellite Instability in Asian Gastric Cancer Patients Enrolled in the ARTIST Trial |
5 |
| Risk Factors for Chemotherapy-Related Toxicity and Adverse Events in Elderly Thai Cancer Patients: A Prospective Study |
5 |
| Clinically Observed Estrogen Receptor Alpha Mutations within the Ligand-Binding Domain Confer Distinguishable Phenotypes |
5 |
| Retrospective Analyses of Systemic Chemotherapy and Cytoreductive Surgery for Patients with Ovarian Metastases from Colorectal Cancer: A Single-Center Experience |
5 |
| Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients |
4 |
| Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Docetaxel/Cisplatin/5-Fluorouracil Followed by Surgery |
4 |
| Real-World Treatment Patterns, Survival, and Prediction of CNS Progression in ALK-Positive Non-Small-Cell Lung Cancer Patients Treated with First-Line Crizotinib in Latin America Oncology Practices |
4 |
| A Phase 2 Study of PCI-2 a Factor VIIa Inhibitor in Combination with Gemcitabine for Advanced Pancreatic Cancer |
4 |
| Predictive Factors of Eribulin Activity in Metastatic Breast Cancer Patients |
4 |
| Tropomyosin-Related Kinase Receptor and Neurotrophin Expression in Cutaneous Melanoma Is Associated with a Poor Prognosis and Decreased Survival |
4 |
| Combination of Resection and Ablative Treatment for Hepatocellular Carcinoma: Usefulness of Complementary Radiofrequency Ablation |
4 |
| Tobacco Cessation in Oncology Care |
4 |
| Ipsilateral Breast Tumor Reappearance and Contralateral Breast Cancer after Primary Breast Cancer Treatment: A Comprehensive Retrospective Study of 168 Patients |
4 |
| Lymphovascular Invasion Increases the Risk of Nodal and Distant Recurrence in Node-Negative Stage I-IIA Non-Small-Cell Lung Cancer |
4 |
| Pros and Cons of the New Edition of TNM Classification of Head and Neck Squamous Cell Carcinoma |
4 |
| Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis |
4 |
| The Expression of HSD17B12 Is Associated with COX-2 Expression and Is Increased in High-Grade Epithelial Ovarian Cancer |
4 |
